Profiling of phosphoinositide molecular species in human and mouse platelets identifies new species increasing following stimulation

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1121-1131. doi: 10.1016/j.bbalip.2018.06.009. Epub 2018 Jun 12.

Abstract

Phosphoinositides are bioactive lipids essential in the regulation of cell signaling as well as cytoskeleton and membrane dynamics. Their metabolism is highly active in blood platelets where they play a critical role during activation, at least through two well identified pathways involving phospholipase C and phosphoinositide 3-kinases (PI3K). Here, using a sensitive high-performance liquid chromatography-mass spectrometry method recently developed, we monitored for the first time the profiling of phosphatidylinositol (PI), PIP, PIP2 and PIP3 molecular species (fatty-acyl profiles) in human and mouse platelets during the course of stimulation by thrombin and collagen-related peptide. Furthermore, using class IA PI3K p110α or p110β deficient mouse platelets and a pharmacological inhibitor, we show the crucial role of p110β and the more subtle role of p110α in the production of PIP3 molecular species following stimulation. This comprehensive platelet phosphoinositides profiling provides important resources for future studies and reveals new information on phosphoinositides biology, similarities and differences in mouse and human platelets and unexpected dramatic increase in low-abundance molecular species of PIP2 during stimulation, opening new perspectives in phosphoinositide signaling in platelets.

Keywords: Phosphoinositide 3-kinase; Phosphoinositides; Platelet activation; Profiling of molecular species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Platelets / cytology
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Carrier Proteins / pharmacology
  • Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors
  • Class I Phosphatidylinositol 3-Kinases / deficiency
  • Class I Phosphatidylinositol 3-Kinases / genetics*
  • Enzyme Inhibitors / pharmacology
  • Gene Expression
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Peptides / pharmacology
  • Phosphatidylinositol 4,5-Diphosphate / metabolism*
  • Phosphatidylinositol Phosphates / metabolism*
  • Platelet Activation / drug effects
  • Primary Cell Culture
  • Protein Subunits / antagonists & inhibitors
  • Protein Subunits / deficiency
  • Protein Subunits / genetics
  • Pyrimidinones / pharmacology
  • Thrombin / pharmacology
  • ortho-Aminobenzoates / pharmacology

Substances

  • 2-(1-(7-methyl-2-morpholin-4-yl-4-oxo-4H-pyrido(1,2-a)pyrimidin-9-yl)ethylamino)benzoic acid
  • Carrier Proteins
  • Enzyme Inhibitors
  • Peptides
  • Phosphatidylinositol 4,5-Diphosphate
  • Phosphatidylinositol Phosphates
  • Protein Subunits
  • Pyrimidinones
  • collagen-related peptide
  • ortho-Aminobenzoates
  • phosphatidylinositol 3,4,5-triphosphate
  • phosphatidylinositol 3-phosphate
  • 1-phosphatidylinositol 3-kinase p110 subunit, mouse
  • Class I Phosphatidylinositol 3-Kinases
  • Thrombin